Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

2.52
-0.5900-18.97%
Post-market: 2.520.00000.00%19:58 EDT
Volume:1.24M
Turnover:3.21M
Market Cap:6.01M
PE:-0.01
High:2.74
Open:2.69
Low:2.41
Close:3.11
Loading ...

ReShape Lifesciences Inc. Files Prospectus for $2.6 Million Public Offering

Reuters
·
13 Jun

ReShape Lifesciences signs exclusive distribution agreement with Recon Supply

TIPRANKS
·
12 Jun

ReShape Lifesciences® Signs Exclusive Distribution Agreement With Recon Supply to Access the Va and Dod Markets

THOMSON REUTERS
·
12 Jun

Top Midday Decliners

MT Newswires Live
·
10 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Copper miners, Chip Stocks, EchoStar

Reuters
·
10 Jun

ReShape Lifesciences Prices $2.6 Million Share Offering

MT Newswires Live
·
10 Jun

ReShape Lifesciences Inc. Announces $2.64M Public Offering and $3.64M ATM Share Sale

Reuters
·
09 Jun

US Stocks Mixed; Motorcar Parts of America Posts Upbeat Earnings

Benzinga
·
09 Jun

ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering

THOMSON REUTERS
·
09 Jun

Top Midday Gainers

MT Newswires Live
·
04 Jun

ReShape Lifesciences announces EU MDR certification for European, UK portfolio

TIPRANKS
·
03 Jun

Top Premarket Decliners

MT Newswires Live
·
02 Jun

ReShape Lifesciences : Entered Into Equity Distribution Agreement Relating to Sale of up to $9.7 Mln of Shares of Common Stock

THOMSON REUTERS
·
31 May

ReShape Lifesciences Inc. Announces $9.7 Million At-the-Market Public Offering Agreement with Maxim Group LLC

Reuters
·
31 May

ReShape Lifesciences Inc. Faces Potential Nasdaq Delisting After Failing to Meet Equity Requirement

Reuters
·
31 May

Reshape Lifesciences Q1 EPS $18.98 Up From $(135.37) YoY, Sales $1.11M Down From $1.94M YoY

Benzinga
·
21 May

ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
21 May

Press Release: ReShape Lifesciences(R) Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update

Dow Jones
·
21 May

ReShape Lifesciences Inc. Delays Q1 2025 Financial Report Due to Reverse Stock Split Adjustments

Reuters
·
16 May

BRIEF-Reshape Lifesciences Inc Files For Mixed Shelf Offering Of Up To $50 Million - SEC Filing

Reuters
·
10 May